TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.980
-0.030 (-0.75%)
Nov 4, 2024, 4:00 PM EST - Market closed

TriSalus Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
24.7418.5112.48.45.43
Revenue Growth (YoY)
67.75%49.31%47.58%54.60%-
Cost of Revenue
3.052.612.261.192.2
Gross Profit
21.6815.9110.147.213.24
Selling, General & Admin
46.6140.5525.2217.0213.06
Research & Development
27.5329.5121.3614.2215.83
Operating Expenses
74.1470.0646.5831.2428.88
Operating Income
-52.45-54.15-36.44-24.03-25.65
Interest Expense
-0.89-0.02-0-1.76-6.04
Interest & Investment Income
0.550.430.18--
Other Non Operating Income (Expenses)
-21.54-15.59-10.92-0.46-0.14
EBT Excluding Unusual Items
-74.33-69.32-47.18-26.25-31.83
Other Unusual Items
19.9910.29--2.59-
Pretax Income
-54.34-59.03-47.18-28.84-31.83
Income Tax Expense
0.010.010.0100
Net Income
-54.35-59.04-47.19-28.85-31.83
Preferred Dividends & Other Adjustments
2.864.242.83--
Net Income to Common
-57.21-63.28-50.02-28.85-31.83
Shares Outstanding (Basic)
219098
Shares Outstanding (Diluted)
219098
Shares Change (YoY)
15.73%2934.71%-96.51%15.52%-
EPS (Basic)
-2.73-6.73-161.55-3.25-4.15
EPS (Diluted)
-2.73-6.73-161.55-3.25-4.15
Free Cash Flow
-55.27-50.63-32.97-23.79-16.13
Free Cash Flow Per Share
-2.63-5.39-106.48-2.68-2.10
Gross Margin
87.65%85.93%81.79%85.80%59.55%
Operating Margin
-212.06%-292.53%-293.91%-286.06%-471.95%
Profit Margin
-231.27%-341.83%-403.42%-343.35%-585.76%
Free Cash Flow Margin
-223.44%-273.53%-265.91%-283.23%-296.74%
EBITDA
-51.7-53.45-36.04-23.57-25.33
EBITDA Margin
-209.02%-288.74%-290.70%-280.54%-
D&A For EBITDA
0.750.70.40.460.32
EBIT
-52.45-54.15-36.44-24.03-25.65
EBIT Margin
-212.06%-292.53%-293.91%-286.06%-
Source: S&P Capital IQ. Standard template. Financial Sources.